A new multiple sclerosis (MS) drug, siponimod (Mayzent), significantly improves cognition for patients with advanced disease, new research shows. Results of a randomized placebo controlled trial ...

BARCELONA, Spain — A new phase 3 trial of ocrelizumab in primary progressive multiple sclerosis (PPMS) showed meaningful benefit in older patients and those with advanced disease — a first for this ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed ...

Researchers from Kyushu University have identified a potential therapeutic target for the treatment of advanced multiple sclerosis (MS), a potentially disabling condition associated with the central ...

MINNEAPOLIS - Finding treatments for advanced multiple sclerosis (MS) has been difficult. But new research may help neurologists identify which drugs are best for people with the advanced form of MS ...

Dysphagia, or difficulty swallowing, is a disorder that can be a symptom of many neurological health conditions, including multiple sclerosis (MS). Dysphagia is a common issue in people with advanced ...

Researchers say a multiple sclerosis drug meant to slow physical disability also shows promise in improving mental acuity in people who are living with secondary progressive MS, an advanced form of ...

Luca Peruzzotti-Jametti has received finding from National Multiple Sclerosis Society, Canadian Institutes of Health Research, CureSearch for Children's Cancer, Wings for Life, Wellcome Trust, ...